Hanchang Biotech Supplies Bio Food Waste Processors with Aramark... "Accelerating ESG Business"

[Asia Economy Reporter Jang Hyowon] Hanchang Biotech announced on the 24th that it has decided to supply the microorganism-based bio food waste processor ‘Meoms’ to Aramark.

Aramark, headquartered in the United States, is one of the world's top three food service companies with annual sales of approximately 17 trillion KRW. Currently, in South Korea, it operates about 350 group catering facilities targeting large corporations such as CJ Freshway and Hyundai SNS.

Hanchang Biotech recently incorporated a new product that processes food waste using bio-microorganisms into its existing bio business division and selected it as a new growth engine.

To actively promote its ESG business, Hanchang Biotech completed the establishment of a management system based on the exclusive distribution contract for the bio food waste processor ‘Meoms,’ focusing on environment, customer needs, and thorough service as core values. By supplying the ‘Meoms’ product to the 350 nationwide group catering facilities owned by Aramark, one of the world's top three food service companies, the company plans to not only aggressively target the food waste processor market but also accelerate its ESG business.

Choi Seunghwan, CEO of Hanchang Biotech, stated, “Taking this supply contract with Aramark as an opportunity, we will expand additional supply contracts through the development of various sales channels. In particular, through this, we plan to establish a nationwide sales network aiming to become the number one company in the domestic individual food waste processor product market in 2022.”

He added, “Together with our parent company Hanchang, we will grow the ESG business into a core main business division of the Hanchang Group and strengthen strategic partnerships with leading domestic and international companies to establish our identity as a representative eco-friendly company that practices ESG management philosophy in business. At the same time, by maximizing synergy with the existing core bio business division of Hanchang Biotech, we will achieve performance growth together.”

This content was produced with the assistance of AI translation services.